Ew. Jabs et al., CYTOGENETIC SURVEY IN SYSTEMIC-SCLEROSIS - CORRELATION OF ANEUPLOIDY WITH THE PRESENCE OF ANTICENTROMERE ANTIBODIES, Cytogenetics and cell genetics, 63(3), 1993, pp. 169-175
Previous cytogenetic studies of patients with systemic sclerosis have
obtained conflicting results regarding the presence of chromosomal ano
malies. We studied 38 patients and 15 controls to determine whether th
ese inconsistencies were due to differences in the subgroups of patien
ts who were studied. Because many patients with systemic sclerosis pro
duce autoantibodies to protein antigens that have been implicated in c
hromosome structure and function, we further hypothesized that the pre
sence of these autoantibodies might correlate with the presence of chr
omosomal anomalies. Patients were classified into clinical subgroups b
ased on the extent of their disease. Their sera were assayed for autoa
ntibodies to topoisomerase I and centromere proteins (CENP-A, CENP-B,
and CENP-C) by immunoblotting. Cytogenetic analyses for aneuploidy and
chromosome breaks were performed. Anticentromere antibody positive (A
CA+) patients had significantly more aneuploidy than either ACA negati
ve (ACA-) patients or controls (P = 0.041). Although the patient group
, when considered as a whole, had significantly greater aneuploidy tha
n the control group (P < 0.005), patients who were ACA- did not have m
ore aneuploidy than the controls had. Patients with Type I disease (sc
lerodactyly), the majority of whom were ACA+, also had significantly m
ore aneuploidy than did either the controls or patients with Type III
(diffuse) disease, most of whom were ACA- (P < 0.005). ACA+ patients a
lso had more chromatid breaks than the controls had (P < 0.05). The co
rrelation between the presence of ACAs and chromosomal aneuploidy sugg
ests that aneuploidy may be the result of nondisjunction secondary to
centromeric dysfunction. In support of this hypothesis, the ACA+ patie
nts who had antibodies to CENP-C exhibited more chromosomal aneuploidy
than did either anti-CENP-A or anti-CENP-B positive patients (P < 0.0
48). Unlike CENP-A and CENP-B, which are present at both functional an
d inactivated centromeres, CENP-C is present at the kinetochore of fun
ctional centromeres.